Trials / Completed
CompletedNCT00538148
Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD
A Multicenter, Multinational, Randomized, DB Controlled Study of the Efficacy & Safety of Oral Telithromycin 800 mg Once QD for 5 Days vs Azithromycin in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 668 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Non-inferiority efficacy of telithromycin versus azithromycin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telithromycin |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2004-09-01
- Completion
- 2004-09-01
- First posted
- 2007-10-02
- Last updated
- 2012-02-17
Source: ClinicalTrials.gov record NCT00538148. Inclusion in this directory is not an endorsement.